How big is the Indonesia Diabetes Care Drugs Market?

The Indonesia Diabetes Care Drugs Market size is expected to reach USD 301.55 million in 2024 and grow at a CAGR of 4.20% to reach USD 370.43 million by 2029. Read More

What is the current Indonesia Diabetes Care Drugs Market size?

In 2024, the Indonesia Diabetes Care Drugs Market size is expected to reach USD 301.55 million. Read More

Who are the key players in Indonesia Diabetes Care Drugs Market?

Eli Lilly, Boehringer Ingelheim, Sanofi, Novo Nordisk and AstraZeneca are the major companies operating in the Indonesia Diabetes Care Drugs Market. Read More

What years does this Indonesia Diabetes Care Drugs Market cover, and what was the market size in 2023?

In 2023, the Indonesia Diabetes Care Drugs Market size was estimated at USD 289.40 million. The report covers the Indonesia Diabetes Care Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Indonesia Diabetes Care Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Indonesia Diabetes Care Drugs Market Share

Statistics for the 2023 & 2024 Indonesia Diabetes Care Drugs market share, created by Mordor Intelligence™ Industry Reports. Indonesia Diabetes Care Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Indonesia Diabetes Care Drugs Industry

The Indonesian Diabetes Care Drugs Market is moderately consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other regional generic players. The market for oral drugs, like Sulfonylureas and Meglitinides, comprises more generic players.